Ivermectin Exerts Anticonvulsant Effects Against Status Epilepticus Induced by Lithium-Pilocarpine in Rats Via GABA Receptor and Neuroinflammation Modulation: Possible Interaction of Opioidergic Pathways and K Channel with Nitrergic System
Overview
Authors
Affiliations
Status epilepticus (SE) is a critical medical emergency marked by persistent or rapidly repeating seizures, posing a threat to life. Using the lithium-pilocarpine-induced SE model, we decide to evaluate the anti-seizure effects of ivermectin as a positive allosteric modulator of GABA receptor and the underlying mechanisms involved. Lithium chloride was injected intraperitoneally at a dose of 127 mg/kg, followed by the administration of pilocarpine at a dose of 60 mg/kg after a 20-h interval in order to induce SE. Subsequently, the rats received varying amounts of ivermectin (0.3, 1, 3, 5, and 10 mg/kg, i.p.) 30 min before the onset of SE. To study the underlying molecular mechanisms, we had pharmacological interventions of diazepam (1 mg/kg), glibenclamide and nicorandil as ATP-sensitive potassium channel blocker and opener (both 1 mg/kg, i.p.), naltrexone and morphine, as opioid receptor antagonist and agonist (1 mg/kg and 0.5 mg/kg, i.p., respectively). In addition, three nitric oxide inhibitors, namely, L-NAME (10 mg/kg, i.p.), 7-NI (30 mg/kg, i.p.), and aminoguanidine (100 mg/kg, i.p.), were administered to the rats in the experiment. Finally, we use ELISA and western blotting, respectively, to examine the amounts of pro-inflammatory cytokines (TNF-α and IL-1β), nitrite, and GABA receptors in the rat hippocampal tissue. The study found that ivermectin, at doses of 3, 5, and 10 mg/kg, exerts anti-seizure effects and decrease Racine's scale SE score. Interestingly glibenclamide and naltrexone reduced the anti-seizure effects of ivermectin, and from other hand diazepam, nicorandil, morphine, L-NAME, 7-NI, and aminoguanidine, enhance the effects when co-administrated with subeffective dose of ivermectin. Additionally, the study found that ivermectin decreased the elevated levels of TNF-α and IL-1β following SE, while increased the reduced expression of GABA receptors. Overall, these findings suggest that ivermectin has anti-seizure effects in a SE seizure which may be mediated by the modulation of GABAergic, opioidergic, and nitrergic pathways and K channels.
Balabandian M, Manavi M, Lesani A, Mohammad Jafari R, Shafaroodi H, Heidari N Pharmacol Res Perspect. 2025; 13(2):e70079.
PMID: 39996441 PMC: 11851161. DOI: 10.1002/prp2.70079.
Lesani A, Mashaknejadian Behbahani F, Manavi M, Mohammad Jafari R, Shafaroodi H, Khosravi S Pharmacol Rep. 2025; .
PMID: 39869286 DOI: 10.1007/s43440-025-00698-6.
Keshavarzi M, Ghasemi M, Manavi M, Dehpour A, Shafaroodi H IBRO Neurosci Rep. 2024; 17:485-492.
PMID: 39717871 PMC: 11664280. DOI: 10.1016/j.ibneur.2024.11.013.
Ivermectin as a promising therapeutic option for onchocerciasis-associated epilepsy.
Manavi M, Mohammad Jafari R, Shafaroodi H, Sharifzadeh M, Dehpour A Epilepsia Open. 2024; 10(1):361-367.
PMID: 39585722 PMC: 11803276. DOI: 10.1002/epi4.13107.
Jouyban K, Mohammad Jafari R, Charkhpour M, Rezaei H, Seyfinejad B, Manavi M Aesthetic Plast Surg. 2024; 48(17):3500-3509.
PMID: 38755497 DOI: 10.1007/s00266-024-04119-6.